New Assay Platform Enhances Detection of Circulating Breast Cancer Cells
NEW YORK (Reuters Health) – Detection of circulating tumor cells (CTCs) in a breast cancer model was improved by a novel assay platform that uses a dual-receptor recognition and signal amplification strategy, researchers say. “Considering the urgent need for early diagnosis of metastatic breast cancer and recent advances in functional nucleic acid-mediated bioassays from our…Continue Reading